A

Apex Healthcare Bhd
KLSE:AHEALTH

Watchlist Manager
Apex Healthcare Bhd
KLSE:AHEALTH
Watchlist
Price: 2.53 MYR -0.78%
Market Cap: 1.8B MYR
Have any thoughts about
Apex Healthcare Bhd?
Write Note

Apex Healthcare Bhd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Apex Healthcare Bhd
Cash & Cash Equivalents Peer Comparison

Comparables:
P
PLABS
R
RHONEMA
Y
YSPSAH
D
DPHARMA
K
KOTRA

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
A
Apex Healthcare Bhd
KLSE:AHEALTH
Cash & Cash Equivalents
myr86.9m
CAGR 3-Years
-20%
CAGR 5-Years
-4%
CAGR 10-Years
6%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Cash & Cash Equivalents
myr17.5m
CAGR 3-Years
-15%
CAGR 5-Years
18%
CAGR 10-Years
21%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Cash & Cash Equivalents
myr31.9m
CAGR 3-Years
9%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Cash & Cash Equivalents
myr139.2m
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
9%
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Cash & Cash Equivalents
myr221.2m
CAGR 3-Years
27%
CAGR 5-Years
23%
CAGR 10-Years
42%
K
Kotra Industries Bhd
KLSE:KOTRA
Cash & Cash Equivalents
myr4.8m
CAGR 3-Years
-14%
CAGR 5-Years
-8%
CAGR 10-Years
-10%

See Also

What is Apex Healthcare Bhd's Cash & Cash Equivalents?
Cash & Cash Equivalents
86.9m MYR

Based on the financial report for Jun 30, 2024, Apex Healthcare Bhd's Cash & Cash Equivalents amounts to 86.9m MYR.

What is Apex Healthcare Bhd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
6%

Over the last year, the Cash & Cash Equivalents growth was -77%. The average annual Cash & Cash Equivalents growth rates for Apex Healthcare Bhd have been -20% over the past three years , -4% over the past five years , and 6% over the past ten years .

Back to Top